FeesSafety
Pluang+

MediWound to host virtual event on EscharEx Phase III trial and $1.05B U.S. market potential

Market News
16 Nov 2026, 15:00 WIB
GlobeNewsWire
View Source
Bullish
MediWound to host virtual event on EscharEx Phase III trial and $1.05B U.S. market potential

MediWound announced a virtual Key Opinion Leader event on December 2, 2026, to discuss the Phase III VALUE study of EscharEx, a biologic for chronic wound care. Experts will review clinical data, treatment landscape, and the drug's commercial potential, estimated at $1.05 billion in U.S. peak sales. The event will also cover future development plans for diabetic foot and pressure ulcers. A replay will be available on MediWound's website after the event.

MediWound's upcoming virtual event on its EscharEx Phase III VALUE study provides context for healthcare sector interest. For readers following health stocks, here is Pluang's market snapshot as of Nov 16, 2026 19:13 WIB: out of 150 priced US health-sector stocks, 67 rose and 61 fell. Notable movers include BKD at USD 8.85 (-3.49%), TNGX at USD 24.64 (-3.37%), and GH at USD 147.01 (-3.18%).

More News

GitGuardian expands program to alert companies of leaked credentials, boosting enterprise cybersecurity worldwide.

GitGuardian expands program to alert companies of leaked credentials, boosting enterprise cybersecurity worldwide.

GitGuardian has launched the Enterprise Good Samaritan Program to identify and notify companies about high-impact leaked credentials that could expose their systems to attackers. Using AI and expert analysis, the program traces leaks to affected orga...

Market News
Neutral
27 minutes ago
Saputo renews share buyback plan to repurchase up to 10% of public shares by Nov 2027

Saputo renews share buyback plan to repurchase up to 10% of public shares by Nov 2027

Saputo Inc. has renewed its Normal Course Issuer Bid (NCIB), allowing it to repurchase up to 22.5 million common shares, representing 10% of its public float, from November 19, 2026, to November 18, 2027. This move reflects Saputo's strategy to retur...

Company Fundamentals
Bullish
27 minutes ago
Saputo renews share buyback program to repurchase up to 10% of public shares through Nov 2027.

Saputo renews share buyback program to repurchase up to 10% of public shares through Nov 2027.

Saputo Inc. announced the renewal of its normal course issuer bid, allowing it to repurchase up to 22.5 million ordinary shares, representing 10% of its public float, from November 19, 2026, to November 18, 2027. This move reflects Saputo's ongoing c...

Company Fundamentals
Bullish
27 minutes ago
Newcleo and Curio partner to supply recycled nuclear materials for advanced MOX fuel in US reactors

Newcleo and Curio partner to supply recycled nuclear materials for advanced MOX fuel in US reactors

Newcleo plc and Curio Legacy Ventures announced a collaboration to supply recycled nuclear materials for mixed-oxide (MOX) fuel production at Newcleo's planned US fuel manufacturing facility. This partnership combines Curio's NuCycle recycling techno...

Market News
Bullish
1 hour ago
Duke Robotics reports 38% revenue growth in Q3 2026 and expands IC Drone platform to Greece.

Duke Robotics reports 38% revenue growth in Q3 2026 and expands IC Drone platform to Greece.

Duke Robotics announced a 38% year-over-year revenue increase for Q3 2026, driven by its IC Drone insulator-cleaning activities. The company expanded its IC Drone platform into Greece through a strategic collaboration with CRONOS, identifying potenti...

Company Fundamentals
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App